Clinical impact of aneuploidy on gastric cancer patients - PubMed (original) (raw)

Review

Clinical impact of aneuploidy on gastric cancer patients

Isabel Sánchez-Pérez et al. Clin Transl Oncol. 2009 Aug.

Abstract

Gastric cancer is a leading cause of death worldwide. Nowadays, complete surgical resection and TNM at diagnosis are the main prognostic factors. In spite of this, many patients will have a recurrence after surgery and die within a few months or years. That means that we need more accurate prognostic factors to design specific approaches for individual patients. Chromosome instability is a feature of gastric cancer commonly associated to chromosomal aberrations that leads to major modifications of DNA content globally termed as aneuploidy. In this regard, many authors' opinions diverge regarding the clinical impact of aneuploidy. This review will summarise data on the clinical impact of aneuploidy on clinical practice, the biological mechanisms that underlie chromosomal instability that induces aneuploidy and the relevance of specific chromosomal aneuploidy to cancer biology.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Cell. 2003 Jan;3(1):51-62 - PubMed
    1. World J Gastroenterol. 2007 May 28;13(20):2784-90 - PubMed
    1. J Cell Biol. 1998 Jul 13;142(1):1-11 - PubMed
    1. Curr Biol. 2006 Sep 5;16(17):1705-10 - PubMed
    1. Oncology. 1996 May-Jun;53(3):182-91 - PubMed

Publication types

MeSH terms

LinkOut - more resources